Linagliptin and Nystatin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Linagliptin (linagliptin) and Nystatin (nystatin). Common drug interactions include vascular pseudoaneurysm among females and hypotension among males.

The phase IV clinical study analyzes what interactions people have when they take Linagliptin and Nystatin. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.

What is Linagliptin?

Linagliptin has active ingredients of linagliptin. eHealthMe is studying from 8,112 Linagliptin users. Check the latest studies of Linagliptin.

What is Nystatin?

Nystatin has active ingredients of nystatin. It is often used in thrush. eHealthMe is studying from 33,567 Nystatin users. Check the latest studies of Nystatin.

On Jul, 30, 2026

38 people who take Linagliptin and Nystatin together, and have interactions are studied.

Linagliptin and Nystatin drug interactions.

What are the common drug interactions of Linagliptin and Nystatin, by gender? *:

female:

Vascular pseudoaneurysm (leakage of arterial blood from an artery into the surrounding tissue with a continuing communication between the originating artery and the resultant adjacent cavity)
Visual impairment
Liver injury
Cholangiocarcinoma (a cancer that forms glands or secretes significant amounts of mucins)
Depressed level of consciousness
Somnolence (a state of near-sleep, a strong desire for sleep)
Cardiac failure congestive
Constipation
Nephropathy toxic (damage to kidney due to toxins)
Tremor (trembling or shaking movements in one or more parts of your body)

male:

Hypotension (abnormally low blood pressure)
Kaposi's sarcoma (a tumour caused by human herpes virus)
Emotional distress
Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
Hypertension (high blood pressure)
Malaise (a feeling of general discomfort or uneasiness)
Pain
Pneumonia
Respiratory failure (inadequate gas exchange by the respiratory system)
Sepsis (a severe blood infection that can lead to organ failure and death)

What are the common drug interactions of Linagliptin and Nystatin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Perinephric collection (fluid collections surrounding a kidney)
Diarrhoea
Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
Hypotension (abnormally low blood pressure)
Malaise (a feeling of general discomfort or uneasiness)
Pyrexia (fever)
Sepsis (a severe blood infection that can lead to organ failure and death)
Drug intolerance (drug sensitivity)
Infection
Respiratory arrest (cessation of normal respiration due to failure of the lungs to function effectively)

50-59:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Chronic kidney disease
Emotional distress
Pain
Acute left ventricular failure (heart attack)
Cardiac failure
Cardiac failure congestive
Chronic left ventricular failure (long lasting functional impairment of left ventricle of heart)
Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)

60+:

Tremor (trembling or shaking movements in one or more parts of your body)
Liver injury
Hypotension (abnormally low blood pressure)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Nephropathy toxic (damage to kidney due to toxins)
Pneumonia
Pulmonary oedema (fluid accumulation in the lungs)
Respiratory failure (inadequate gas exchange by the respiratory system)
Thrombosis (formation of a blood clot inside a blood vessel)
Abdominal discomfort

What are the existing conditions these people have? *

Diabetes: 12 people, 31.58%
High Blood Pressure: 12 people, 31.58%
High Blood Cholesterol: 8 people, 21.05%
Anaemia (lack of blood): 7 people, 18.42%
Immunodeficiency Disorders: 7 people, 18.42%
Stress And Anxiety: 6 people, 15.79%
Type 2 Diabetes: 6 people, 15.79%
Insomnia (sleeplessness): 6 people, 15.79%
Calcium Deficiency (lack of calcium): 5 people, 13.16%
Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood): 5 people, 13.16%

* Approximation only. Some reports may have incomplete information.

Do you take Linagliptin and Nystatin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously